Literature DB >> 19336595

Hypersensitivity pneumonitis associated with the use of temozolomide.

D Koschel1, S Handzhiev, V Leucht, O Holotiuk, A Fisseler-Eckhoff, G Höffken.   

Abstract

The aim of the present study was to investigate a case of hypersensitivity pneumonitis associated with the use of temozolomide in the treatment of gliosarcoma. A 54-yr-old female developed dyspnoea, cough and hypoxia after surgical resection for gliosarcoma and adjuvant radio- and chemotherapy with temozolomide. A high-resolution computed tomography scan of the thorax showed a bilateral ground-glass pattern. Bronchoscopy with bronchoalveolar lavage and lung biopsies was performed. Bronchoalveolar lavage demonstrated significant lymphocytic alveolitis and transbronchial lung biopsies revealed lymphocytic infiltration with foamy macrophages, consistent with hypersensitivity pneumonitis. There was no evidence of other causes, including infections. After withdrawing temozolomide and initiating prednisolone therapy, the patient had no further pulmonary symptoms. To the present authors' knowledge, this is the first definitively described case of temozolomide-associated hypersensitivity pneumonitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336595     DOI: 10.1183/09031936.00004808

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

1.  Organized Pneumonia Secondary to Increasing Doses of Temozolomide.

Authors:  Pedro J Marcos; Angélica Consuegra Vanegas; María Matachana Martínez; Lourdes Cordero Lorenzana; Iria Vidal García; Carmen Montero Martínez
Journal:  Cureus       Date:  2015-09-09

Review 2.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

3.  Longstanding hypersensitivity pneumonitis and its response to roflumilast: A review of its likely immunological effects.

Authors:  V A Varney; G Quirke; Alaa Witwit; A S Bansal
Journal:  Respir Med Case Rep       Date:  2022-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.